1)The American Psychiatric Association:Practice guideline for the pharmacological treatment of patients with alcohol use disorder. https://psychiatryonline.org/doi/pdf/10.1176/appi.books.9781615371969(2020年1月15日閲覧)
2)Slade T, Chiu WT, Glantz M, et al:A cross-national examination of differences in classification of lifetime alcohol use disorder between DSM-Ⅳ and DSM-5:findings from the world mental health survey. Alcohol Clin Exp Res 40:1728-1736, 2016
3)Grand BF, Goldstein RB, Saha TD, et al:Epidemiology of DSM-5 alcohol use disorder:results from the national epidemiology survey on alcohol and related conditions Ⅲ. JAMA Psychiatry 72:757-766, 2015
4)Bouchery EE, Harwood HJ, Stacks JJ, et al:Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prev Med 41:516-524, 2006
5)Kendler KS, Ohlsson H, Sundquist J, et al:Alcohol use disorder and mortality across the life-span:a longitudinal cohort and co-relative analysis. JAMA Psychiatry 73:575-581, 2016
6)Institute of Medicine, Committee on Quality of Health Care in America:Crossing the Quality Chasm:a new health system for the 21st Century. National Academies Press, Washington D.C., 2001
7)Institute of Medicine:Clinical Practice Guidelines We Can Trust. National Academies Press, Washington D.C., 2011
8)新アルコール・薬物使用障害の診断治療ガイドライン作成委員会監修,樋口進,齋藤利和,湯本洋介編:新アルコール・薬物使用障害の診断治療ガイドライン.新興医学出版社,2018